ANDA 211831, held by Regcon Holdings. Thiotepa.
As of Nov 13, 2026, ANDA 211831 (Thiotepa), held by Regcon Holdings, was first approved by FDA on Dec 8, 2021, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 8, 2021 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Thiotepa15MG/VIAL ยท injectable;injection | Thiotepa | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
